|
English
|
正體中文
|
简体中文
|
总笔数 :0
|
|
造访人次 :
51908633
在线人数 :
906
教育部委托研究计画 计画执行:国立台湾大学图书馆
|
|
|
"chuang tc"的相关文件
显示项目 11-18 / 18 (共1页)
1
每页显示[10|25|50]项目
| 中國醫藥大學 |
2005 |
Nitric oxide induces prion protein via MEK and p38 MAPK signaling
|
Wang, VC; Chuang, TC; Hsu, YD; Chou, WY; Kao, MC |
| 淡江大學 |
2003-08 |
EBNA1 may prolong G2/M phase and sensitizes HER2/neu-overexpressing ovarian cells to both topoisomerase II-targeting and paclitaxel drugs
|
Chuang, TC; Lee, YJ; Liu, JY; Lin, YS; Lee, JW; Wang, V; Law, SL; Kao, Ming-Ching |
| 中國醫藥大學 |
2003-08 |
EBNA1 may prolong G2/M phase and sensitize HER2/neu-overexpressing ovarian cancer cells to both topoisomerase II-targeting and paclitaxel drugs
|
(Chuang TC); (Lee YJ); (Liu JY); (Lin YS); (Lee JW); (Wang V); (Law SL); 高銘欽(Ming-Ching Kao)* |
| 中國醫藥大學 |
2003-08 |
EBNA1 may prolong G(2)/M phase and sensitize HER2/neu-overexpressing ovarian cancer cells to both topoisomerase II-targeting and paclitaxel drugs
|
(Chuang TC); (Lee YJ); (Liu JY); (Lin YS); (Li JW); (Wang V); (Law SL); 高銘欽(Ming-Ching Kao)* |
| 中國醫藥大學 |
2002-11 |
The Epstein–Barr virus nuclear antigen-1 may act as a transforming suppressor of the HER2/neu oncogene
|
(Chuang TC); 魏宗德; (Lin YS); (Lee YC); (Law SL); 高銘欽(Ming-Ching Kao)* |
| 中國醫藥大學 |
2002-01 |
The N-terminal domain of SV40 large T antigen represses the HER2/neu-mediated transformation and metastatic potential in breast cancers
|
(Chuang TC); (Yu YH); (Lin YS); (Wang SS); 高銘欽(Ming-Ching Kao)* |
| 中國醫藥大學 |
1998-06 |
The N-terminal 178-amino-acid domain only of the SV40 large T antigen act as a transforming suppressor of the HER2/neu oncogene
|
高銘欽(Ming-Ching Kao)*; (Liu KY); (Chuang TC); (Lin YS); (Wuu JA); (Law SL) |
| 中國醫藥大學 |
1998-05 |
In vitro gene delivery in mammalian cells via a new cationic liposome formulation
|
高銘欽(Ming-Ching Kao)*; (Law SL); (Chuang TC); (Lin YS) |
显示项目 11-18 / 18 (共1页)
1
每页显示[10|25|50]项目
|
